ReviewJournal of managed care & specialty pharmacy2020

Real-World Clinical and Economic Outcomes Associated with Palbociclib for HR-Positive/HER2 Negative Metastatic Breast Cancer: A Commentary.

Aram Babcock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.